Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2

NCT: NCT05708976 · COMPLETED

NCT IDNCT05708976
StatusCOMPLETED
Start Date2023-02-15
Completion2024-09-30

Brief Summary

This randomized two-arm intervention trial administers 8 weekly cognitive behavioral therapy (CBT) sessions and 4 bi-weekly active whole-body hyperthermia (active WBH) sessions or 4 bi-weekly sham WBH sessions to adults aged 18 years or older with major depressive disorder (MDD).

Frequently Asked Questions

What is HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2?

HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2 is a clinical trial registered under NCT05708976. Current status: COMPLETED.

What is the status of NCT05708976?

The current status of NCT05708976 (HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2) is: COMPLETED.

When did HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2 start?

HypErthermia as an Additional Treatment for the Biology and Experience of Depression: Study 2 started on 2023-02-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑